Early Versus Delayed Initiation of Disease-Modifying Antirheumatic Drugs in Rheumatoid Arthritis.

被引：0
|
作者：
Van Doornum, Sharon [1 ]
Roberts, Lynden [2 ]
Reed, Mark D. [3 ]
Liew, Danny [1 ]
机构：
[1] Univ Melbourne, Melbourne, Vic, Australia
[2] James Cook Univ, Townsville, Qld, Australia
[3] Sir Charles Gairdner Hosp, Nedlands, WA 6009, Australia
来源：
ARTHRITIS AND RHEUMATISM | 2012年 / 64卷 / 10期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
1836
引用
收藏
页码：S781 / S781
页数：1
相关论文
共 50 条
  • [1] Risk Of Venous Thromboembolism and Use Of Disease-Modifying Antirheumatic Drugs For Rheumatoid Arthritis.
    Kim, Seoyoung C.
    Solomon, Daniel H.
    Liu, Jun
    Franklin, Jessica M.
    Glynn, Robert J.
    Schneeweiss, Sebastian
    [J]. ARTHRITIS AND RHEUMATISM, 2013, 65 : S156 - S157
  • [2] Approaches to the treatment of early rheumatoid arthritis with disease-modifying antirheumatic drugs
    Sizova, Lyudmila
    [J]. BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 2008, 66 (02) : 173 - 178
  • [3] THE EARLY USE OF DISEASE-MODIFYING ANTIRHEUMATIC DRUGS IN RHEUMATOID-ARTHRITIS
    MONGAN, ES
    [J]. ARTHRITIS AND RHEUMATISM, 1990, 33 (03): : 451 - 451
  • [4] Survival of Disease-Modifying Antirheumatic Drugs in Rheumatoid Arthritis
    Rosales Rosado, Zulema
    Leon, Leticia
    Freites Nunez, Dalifer
    Font Urgelles, Judit
    Leon Cardenas, Cynthia Milagros
    Vadillo Font, Cristina
    Rodriguez Rodriguez, Luis
    Jover Jover, Juan A.
    Abasolo Alcazar, Lydia
    [J]. ARTHRITIS & RHEUMATOLOGY, 2016, 68
  • [5] Conventional disease-modifying antirheumatic drugs in early arthritis
    Sokka, T
    Hannonen, P
    Möttönen, T
    [J]. RHEUMATIC DISEASE CLINICS OF NORTH AMERICA, 2005, 31 (04) : 729 - +
  • [6] Disease-modifying antirheumatic drugs and bone mass in rheumatoid arthritis
    Di Munno, O
    Delle Sedie, A
    Rossini, A
    Adamil, S
    [J]. CLINICAL AND EXPERIMENTAL RHEUMATOLOGY, 2005, 23 (02) : 137 - 144
  • [7] Termination of disease-modifying antirheumatic drugs in rheumatoid arthritis and in psoriatic arthritis.: A comparative study of 270 cases
    Ujfalussy, I
    Koó, P
    Seszták, M
    Gergely, P
    [J]. ZEITSCHRIFT FUR RHEUMATOLOGIE, 2003, 62 (02): : 155 - 160
  • [8] Conventional disease-modifying antirheumatic drugs to treat rheumatoid arthritis
    Rath, T.
    Sander, O.
    Rubbert, A.
    [J]. DRUG DEVELOPMENT RESEARCH, 2011, 72 (08) : 657 - 663
  • [9] Safety of biological disease-modifying antirheumatic drugs in rheumatoid arthritis
    Martinez-Mugica, Cristina
    Salgueiro, Esther
    [J]. FARMACIA HOSPITALARIA, 2022, 46 (01) : 15 - 20
  • [10] Cost Effectiveness Analysis of Disease-Modifying Antirheumatic Drugs in Rheumatoid Arthritis. A Systematic Review Literature
    Benucci, Maurizio
    Saviola, Gianantonio
    Manfredi, Mariangela
    Sarzi-Puttini, Piercarlo
    Atzeni, Fabiola
    [J]. INTERNATIONAL JOURNAL OF RHEUMATOLOGY, 2011, 2011
12345